McBroom & Associates LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 0.2% in the fourth quarter, Holdings Channel reports. The fund owned 18,505 shares of the medical equipment provider’s stock after selling 35 shares during the period. Intuitive Surgical comprises approximately 5.5% of McBroom & Associates LLC’s holdings, making the stock its 4th biggest position. McBroom & Associates LLC’s holdings in Intuitive Surgical were worth $9,659,000 at the end of the most recent reporting period.
Several other institutional investors have also recently added to or reduced their stakes in the company. M.E. Allison & CO. Inc. acquired a new position in Intuitive Surgical in the fourth quarter worth $449,000. Seilern Investment Management Ltd bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $82,517,000. Exome Asset Management LLC lifted its position in shares of Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Sycomore Asset Management grew its stake in shares of Intuitive Surgical by 27.4% during the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. increased its holdings in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares in the last quarter. 83.64% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of research analysts have commented on the company. UBS Group increased their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Bernstein Bank lifted their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday, January 27th. Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. Mizuho lifted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, Truist Financial increased their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $613.10.
Intuitive Surgical Stock Up 2.2 %
Intuitive Surgical stock opened at $595.70 on Tuesday. The company has a 50 day moving average of $554.85 and a 200-day moving average of $514.80. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a market capitalization of $212.18 billion, a PE ratio of 92.93, a price-to-earnings-growth ratio of 5.67 and a beta of 1.39.
Insider Buying and Selling
In related news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 5,940 shares of company stock valued at $3,346,964. Company insiders own 0.90% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How to Use Stock Screeners to Find Stocks
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- The How And Why of Investing in Oil Stocks
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.